Gutron (Midodrine Hydrochloride)

Gutron is indicated for the management of symptomatic orthostatic hypotension, a condition characterized by a significant drop in blood pressure upon standing.

• Increases standing systolic blood pressure in patients with neurogenic orthostatic hypotension.
• Used as adjunct therapy when non‑pharmacologic measures (e.g., compression stockings, fluid intake) are insufficient.
• May be prescribed for patients with chronic autonomic failure causing postural dizziness.
• Considered when rapid improvement of blood pressure is required to reduce fall risk.

The safety profile of Gutron includes a range of observed adverse events, which are categorized by frequency and clinical significance.

Common

• Piloerection (goose‑skin appearance).
• Pruritus or itching.
• Urinary urgency or frequency.
• Supine hypertension (elevated blood pressure while lying down).
• Headache.
• Nausea.
• Flushing.

Serious

• Severe supine hypertension leading to cardiovascular complications.
• Reflex bradycardia or arrhythmia.

When prescribing Gutron, clinicians should evaluate patient-specific factors and monitor for conditions that could be worsened by its pharmacologic action.

• Avoid use in patients with severe supine hypertension.
• Monitor blood pressure regularly, especially after dose adjustments.
• Caution in individuals with cardiovascular disease, such as ischemic heart disease.
• Use carefully in patients with renal or hepatic impairment, as drug clearance may be altered.
• Assess for urinary retention or bladder outflow obstruction before initiating therapy.
• Consider dose reduction in elderly patients due to increased sensitivity.

Gutron can interact with other medications, influencing blood pressure control or increasing the risk of adverse effects.

Avoid

• Concomitant use with other vasopressor agents (e.g., phenylephrine) may cause excessive hypertension.
• Combined with monoamine oxidase inhibitors (MAOIs) can potentiate pressor effects.
• Use with centrally acting antihypertensives (e.g., clonidine) may lead to unpredictable blood pressure changes.

Use with caution

• Concurrent diuretics may exacerbate orthostatic symptoms if volume depletion occurs.
• Beta‑blockers may blunt compensatory tachycardia, increasing risk of supine hypertension.
• NSAIDs can affect renal function, potentially altering drug clearance.